Abstract
A wealth of scientific literature backs the unique therapeutic benefits of exercise for quality of life, cardiovascular (CV) health, and longevity. Consequently, many have assumed that more exercise is always better. However, chronic excessive endurance exercise might adversely impact CV health. Ultra-endurance races can inflict acute myocardial damage, as evidenced by elevations in troponin and brain natriuretic peptide. Moreover, sudden cardiac arrest occurs more often in marathons and triathlons than in shorter races. Veteran endurance athletes often show abnormal cardiac remodeling with increased risk for myocardial fibrosis and coronary calcification. Chronic excessive exercise has been consistently associated with increased risks of atrial fibrillation (AF), and along with some attenuation of longevity benefits. The optimal dose of exercise remains unknown and probably differs among individuals. Current studies suggest that 2.5 to 5 hours/week of moderate or vigorous physical activity will confer maximal benefits; >10 hours/week may reduce these health benefits.
Introduction
Physical inactivity and obesity are among the leading causes of death and disability, with myriad adverse effects, especially for the cardiovascular (CV) system. Today in the United States (U.S.) about half of all adults have some form of CV disease (CVD).1 Thus, physical activity and exercise training have become among our most powerful tools for the prevention and treatment of noncommunicable disease—CVD in particular.2 Physical activity and an improved cardiorespiratory fitness lessen the incidence and burden of coronary artery disease (CAD) and reduces risk of major adverse CVD events (MACE). Each metabolic equivalent (MET) gain in fitness confers a 30% reduction in all-cause mortality in unfit individuals (those with an initial < 5 MET exercise capacity).3 The most physically active cohort in middle age has a predicted life expectancy eight years longer than a sedentary cohort; and for patients with established CVD, undertaking cardiac rehabilitation consistently improves prognosis and quality of life.4
Exercise positively affects virtually every aspect of the body and brain, and its unique ability to improve physical and mental wellbeing has convinced the general public that staying physically active is one of the best ways to stay healthy and enhance longevity. In fact, maintaining a high level of CV fitness (aerobic and muscular fitness) improves prognosis independently of other therapies, and plausible arguments can be made that exercise/fitness is the most potent medical therapy we have in the battle against CVD.5 Although the ideal dose of exercise remains unknown; it is clear that at least half of Americans are not meeting the physical activity guidelines recommendations of > 150 minutes/week of moderate exercise. Importantly, significant longevity benefits are conferred by even just 15 minutes/day of light or moderate physical activity, which is about half the recommended minimum dose of daily exercise, with the steepest risk reductions seen in the cohort going from completely sedentary to just mildly active.6 At the other end of the spectrum, about 2.5% of U.S. adults may be overdoing exercise, thereby exposing themselves to potential deleterious health outcomes.7
The ideal dose of exercise for conferring robust health and optimal longevity is being hotly debated in the scientific literature. The aim of this article is to clarify this issue, focusing on the cumulative data.8–14
Reverse J-Curves of Exercise
The optimal dose of physical activity for maximizing health benefits is unknown,15 and even 2,500 years ago, Hippocrates taught: “if we could give every individual the right amount of nourishment and exercise—not too little and not too much—we would have found the safest way to health.”7 This suggests that there might be a dose range of physical activity that is optimal for improving wellbeing and life expectancy, with attenuation of these benefits when the amount of exercise is above or below this ideal range. Indeed, Paffenbarger back in 1986 reported a reverse J-shaped association between exercise (walking, stair climbing, and sports play) and all-cause mortality. That prospective study followed 16,936 male Harvard alumni for 16 years and found that death rates declined inversely as energy expended on physical activity increased from < 500 to 3,500 kcal/week.16 However, the 18% of men exercising > 3,500 kcal/week had attenuation of the age-adjusted reduction in risk of death, showing a 38% reduction compared to a 54% mortality reduction for those doing 3,000 to 3,500 kcal/week.16
Since then multiple large observational studies, together comprising over three million individuals, have reported similar results suggesting there is likely an upper threshold for the benefit of exercise whereby very high doses of strenuous physical activities appear to be associated with loss of some of the longevity benefits conferred by less extreme doses of vigorous exercise. As depicted in Figure 1, nearly all of the large observational studies reproduce this reverse J-curve. In this relationship, the risks of CVD and premature mortality go down in dose dependent fashion, until a threshold of exercise is exceeded, at which point the benefits are attenuated compared to less extreme doses of physical activity. In many studies the drop-off in risk reduction noted with very high dose exercise did not reach statistical significance due to the small number of individuals in the upper extreme cohort. Yet, this reverse-J pattern is recurring theme, and in very large studies the attenuation of health benefits noted with extremely high doses of exercise does meet statistical significance.8
Arrhythmias
Physical exercise has been associated with a number of CV adaptations, both structural and electrical, including enlargement of all chambers of the heart, improved function, increased cardiac and arterial compliance, sinus bradycardia, and in some individuals increased PR interval and right bundle branch block.17,18 The increased incidence of atrial fibrillation (AF) seen in endurance athletes is one of the best documented cardiac maladaptations and is thought to be one of the hallmark characteristics of cardiac overuse syndrome. In 1998 Karajalainen et al. examined 300 veteran endurance athletes and reported a five-fold greater incidence of AF as compared to a sedentary control cohort.19 AF since then has been associated with higher intensity exercise regimens, faster competitive finishing times and absolute number of endurance races completed.20 Long-term endurance exercise— ≥ 2,000 hours and/or ≥ 20 years of training—displays a strong correlation with AF even in individuals without CV risk factors.21,22 While individual studies have reported that chronic endurance sports participation increases risk of AF anywhere between two- and ten-fold, a recent meta-analyses quantified an odds ratio for overall risk of AF at just above five-fold.23
Similar to many other health outcomes, moderate doses of physical activity are effective in preventing AF, whereas both low and high volumes of exercise are associated with increased risk of AF. As compared to more fit subjects, those with < 6 METs exercise capacity showed elevated incident rates of AF, and after adjustment each 1 MET gain in fitness was associated with a 7% lower risk of incident AF (hazard ratio 0.93, 95% confidence interval 0.92–0.94, P<0.001).24 In regards to weekly dose of physical activity, even small doses of exercise, such beginning with 5 MET-hours/ week appear to reduce risk of AF, with maximal benefits seen at 20 MET-hours/week (Figure 2).25 Above 55 MET-hours/week, which is approximates to 10 hours of vigorous exercise/week, the risk of developing AF begins to exceed that of the sedentary cohort, displaying a J-curve relationship.25
Atrial flutter and/or AF were noted in a significant cohort of former Swiss professional cyclists.26 Following the successful ablation of atrial flutter, previous endurance sport participation and an ongoing practice of high level exercise increased the risk of recurrent AF.27 Furthermore, a group of former professional cyclists had a five-fold increased prevalence of ventricular tachycardia as compared to 309 male senior leisure time golfers (15% vs. 3%, P=0.05).26 Although complex ventricular tachyarrhythmias are sometimes seen in competitive athletes, and have been included as one manifestation of the “athlete’s heart syndrome,” it is unclear whether this constitutes a benign or high-risk cardiac condition.28,29 Some authors argue that the adverse structural changes in the ventricles and atria induced by chronic strenuous endurance exercise produces the substrate for a development and progression of a proarrhythmogenic state.30 Other potential contributors to arrhythmias in veteran endurance athletes include: excessive sympathetic activity/catecholamine overload, increased oxidative stress, myocardial fibrosis, electrolyte abnormalities.
Myocardial Fibrosis
Myocardial fibrosis is a nonspecific response to a variety of cardiac injuries such as: acute myocardial infarction (MI), myocarditis, uncontrolled hypertensionand valvular dysfunction. This pathological fibrosis in the heart predisposes to myocardial stiffness, arrhythmias and adverse cardiac outcomes.31 Myocardial fibrosis is best visualized with cardiac magnetic resonance imaging (MRI), specifically demonstrated by late gadolinium enhancement (LGE).
Chronic endurance sport training/racing has been shown to increase risk of showing LGE, and this has been documented in otherwise healthy, asymptomatic lifelong endurance athletes.31–33 Moreover, LGE is significantly and directly correlated with the number of years spent training, and the number of marathons and other ultra-endurance competitions completed.32,34 During times of strenuous exercise cardiac output increases approximately five-fold above resting values, rising from 5 L/min to 25 L/min or more, leading to disproportionately distributed strain on the heart with increases in wall stress of 125% vs. 4% on the right and left ventricles, respectively.35 These physical strains in conjunction with sustained elevations in catecholamines and reactive oxygen species likely cause cumulative injuries in the myocardium—ultimately leading to scarring as demonstrated by LGE.
The evidence regarding the clinical relevance of this resultant myocardial fibrosis is lacking. One small study of four veteran athletes with LGE reported wall motion abnormalities corresponding to the fibrosed myocardial segments.36 Additionally, during two years of follow-up, MACE and coronary revascularization occurred more commonly among endurance athletes with myocardial LGE compared to veteran athletes without fibrosis, suggesting that this myocardial damage may play a prognostic role.33 Interestingly, not only number of ultra-endurance races completed, but also the severity of coronary artery calcification (CAC) independently predicted presence of LGE.34 The cumulative data on cardiac MRI shows a 12% prevalence of LGE in veteran endurance athletes, which is eight-fold higher than the 1.5% prevalence among the control group of individuals who were doing not more than the minimum dose of daily physical activity recommended by the World Health Organization (Figure 3).15
Coronary Artery Calcification
The evidence in regards to CAC in veteran endurance athletes is complicated. A large and consistent body of data shows that the amount of calcium in the coronary arteries is an accurate predictor of risk for MACE.37 Paradoxically, although exercise decreases CAD risk, high volume endurance training appears to substantially increase the CAC burden with Kermott and colleagues demonstrating the presence of the familiar reverse J-curve (Figure 4).38 Merghani et al. reported that masters athletes 54±8 years of age were approximately twice as likely to have atherosclerotic plaque as compared to healthy controls, and these endurance athletes were more likely to show CAC scores ≥ 300 (11.3%) and luminal stenosis ≥ 50% (7.5%).39
Generally, studies have confirmed that veteran endurance athletes have increased coronary calcification compared to sedentary controls, but they tend to be less likely to have high-risk volatile plaques of mixed calcific and lipid laden morphology.39–41 An observational study of 21,758 individuals found that those with at least 3,000 MET-min/wk had a higher CAC burden compared to less active cohort. Even so, those same highly active individuals showed a nonsignificant trend towards a decrease in mortality (HR 0.77, 95% CI 0.52–1.15) as compared to the less active cohort.40 Another study reported that very-vigorous-intensity exercise was the most strongly predictive of CAC, but was also associated with reduced prevalence of mixed plaques.41 Thus, the veteran athletes doing the highest volumes exercise will often have more coronary calcification, but they also tend to have a more stable and benign plaque composition.41,42
Taken together, these data suggest that very high doses of strenuous physical activity are associated with increased risk of coronary calcification but are not associated with dangerous plaque composition or increased risk of all-cause or CVD mortality, even among veteran athletes with high CAC scores. Much like the evidence for exercise-induced myocardial fibrosis, it is difficult to conclude that CAC and other cardiac maladaptations are completely benign. However, currently the functional relevance of such findings is of undetermined significance and this issue will require more study with larger patient populations of veteran endurance athletes.
Acute Risk Associated with Vigorous Exercise
Up to 90% of all exercise-related sudden cardiac deaths (SCD) occur in recreational athletes rather than competitive athletes, with an estimated incidence raging from 1:22,000–1:69,000 in adult recreational athletes, versus 1:50,000 in young competitive athletes.43,44 The riskiest period for SCD is during and shortly after exercise.15 In the U.S. Physician study, the risk of SCD was transiently elevated 17-fold during and 30 minutes after vigorous physical activity. This risk was much higher in individuals who were the least active when compared to subjects who exercised more often (relative risk 74 vs 11).15 Similarly, another study found that the most sedentary cohort had a 25-fold increase risk of SCD compared to those who were at least moderately active.15 In athletes aged > 35 years, over 80% of the SCDs are cause by CAD; whereas among younger athletes (< 35 years) congenital abnormalities of the heart muscle, coronaries and conduction system are the most common cause of SCD.45
Longer and more physically demanding races appear to pose a higher risk for SCD. Data from almost 11 million long distance race participants showed a higher incidence of SCD in marathons (1.01/100,000) compared to half marathons (0.27/100,000); only 29% of victims survived the cardiac arrest.46 Of note, the death rate of males was more than double of the female race participants (0.98 vs 0.41/100,000).47 This gender difference has been seen with respect to many aspects of the cardiac overuse syndrome, whereby women appear to be less susceptible than men to adverse cardiac effects of chronic high-dose endurance exercise.
The rate of SCD in triathlon athletes has been reported to be higher than marathon races. In a case series of 4.7 million triathlon participants the incidence of SCD was estimated to be 1.74/100,000 participants.48 Similar to marathons, males had three times higher risk when compared to females (2.40 vs 0.74/100,000). Also, there was a three-fold higher risk in men > 40 years when compared to younger participants.48
Acute MI also occurs at an increased rate during or soon after vigorous exercise. Several studies have demonstrated a two- to ten-fold increased risk for MI within one hour of physical activity.15 Endurance events including marathons and ultra-marathons have been associated with derangements in cardiac biomarkers. In marathon runners, significant post-race troponin elevations have been detected in direct correlation with exercise intensity.49 A rise in brain natriuretic peptide levels was also seen in the marathon runners, but these elevations bore no relationship to exercise intensity.49
In addition to biochemical changes, functional changes are also present following intense exercise. One study of 40 athletes competing in endurance races (marathon, endurance triathlon, alpine cycling) found that the post-race right ventricle (RV) ejection fraction (EF) decreased by nine percentage points, with no change in left ventricular (LV) EF. The greatest reduction in RVEF was seen in the athletes who completed the longest event (ultra-triathlon).50 Moreover, LGE on MRI was seen at the site of the RV attachment to the interventricular septum in 13% of the endurance athletes and commonly was seen in conjunction with pulmonary hypertension in these same individuals. Interestingly those athletes who had been competing for more years (20 years vs eight years) had significantly lower resting RVEF.50 Repeated insults to the RV as seen during protracted strenuous exercise could cause myocardial necrosis ultimately leading to scarring and irreversible RV remodeling, creating the substrate for arrhythmias. The approximate amount of exercise required for this effect is speculated to be about > 20 hours/week for > 20 yrs.43
Conclusion
If one’s goal is to decrease the risk of CV events, and improve life expectancy, a regular regimen of moderate activity is adequate. Very high doses of strenuous exercise may attenuate some of the benefits bestowed by less extreme efforts. The best forms of exercise for improving mental health and longevity appear to be social sports such as tennis, golf, badminton, soccer, basketball, volleyball, and group exercise, which not only improves fitness, but also promote interpersonal bonding and tend to reduce stress.51 The current body of data is not strong enough to recommend that recreational athletes reduce their exercise dose, especially if this is something that improves their quality of life, or is needed to optimize performance in competitions, as the risks appear to be modest and somewhat uncertain yet. Even so, we should emphasize that the maximal benefit for CVD risk reduction occurs at much lower, safer and more moderate exercise doses.
Footnotes
From left: Evan L. O’Keefe, MD, is at Tulane Medical Center, New Orleans, Louisiana. Noel Torres-Acosta, MD, is at the University of Kansas Medical Center, Kansas City, Kansas. James H. O’Keefe, MD, MSMA member since 2003, is at Saint Luke’s Mid America Heart Institute, Kansas City, Missouri and University of Missouri-Kansas City, Kansas City, Missouri. Carl J. Lavie, MD, is in the Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, the University of Queensland School of Medicine, New Orleans, Louisiana.
Disclosure
None reported.
References
- 1.Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 Mar 5;139(10):e56–e528. doi: 10.1161/CIR.0000000000000659. [DOI] [PubMed] [Google Scholar]
- 2.Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Circulation. 2003 Jun 24;107(24):3109–3116. doi: 10.1161/01.CIR.0000075572.40158.77. [DOI] [PubMed] [Google Scholar]
- 3.Martin BJ, Arena R, Haykowsky M, et al. Cardiovascular fitness and mortality after contemporary cardiac rehabilitation. Mayo Clin Proc. 2013 May;88(5):455–463. doi: 10.1016/j.mayocp.2013.02.013. [DOI] [PubMed] [Google Scholar]
- 4.Li Y, Pan A, Wang DD, et al. Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population. Circulation. 2018 Jul 24;138(4):345–355. doi: 10.1161/CIRCULATIONAHA.117.032047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Boden WE, Franklin BA, Wenger NK. Physical activity and structured exercise for patients with stable ischemic heart disease. JAMA. 2013 Jan 9;309(2):143–144. doi: 10.1001/jama.2012.128367. [DOI] [PubMed] [Google Scholar]
- 6.Wen CP, Wai JP, Tsai MK, et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet. 2011 Oct 1;378(9798):1244–1253. doi: 10.1016/S0140-6736(11)60749-6. [DOI] [PubMed] [Google Scholar]
- 7.O’Keefe JH, O’Keefe EL, Lavie CJ. The Goldilocks Zone for Exercise: Not Too Little, Not Too Much. Mo Med. 2018 Mar-Apr;115(2):98–105. [PMC free article] [PubMed] [Google Scholar]
- 8.Armstrong ME, Green J, Reeves GK, Beral V, Cairns BJ Million Women Study C. Frequent physical activity may not reduce vascular disease risk as much as moderate activity: large prospective study of women in the United Kingdom. Circulation. 2015 Feb 24;131(8):721–729. doi: 10.1161/CIRCULATIONAHA.114.010296. [DOI] [PubMed] [Google Scholar]
- 9.Arem H, Moore SC, Patel A, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med. 2015 Jun;175(6):959–967. doi: 10.1001/jamainternmed.2015.0533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lee DC, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol. 2014 Aug 5;64(5):472–481. doi: 10.1016/j.jacc.2014.04.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lear SA, Hu W, Rangarajan S, et al. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet. 2017 Dec 16;390(10113):2643–2654. doi: 10.1016/S0140-6736(17)31634-3. [DOI] [PubMed] [Google Scholar]
- 12.Schnohr P, O’Keefe JH, Marott JL, Lange P, Jensen GB. Dose of jogging and long-term mortality: the Copenhagen City Heart Study. J Am Coll Cardiol. 2015 Feb 10;65(5):411–419. doi: 10.1016/j.jacc.2014.11.023. [DOI] [PubMed] [Google Scholar]
- 13.Maessen MF, Verbeek AL, Bakker EA, Thompson PD, Hopman MT, Eijsvogels TM. Lifelong Exercise Patterns and Cardiovascular Health. Mayo Clin Proc. 2016 Jun;91(6):745–754. doi: 10.1016/j.mayocp.2016.02.028. [DOI] [PubMed] [Google Scholar]
- 14.Williams PT, Thompson PD. Increased cardiovascular disease mortality associated with excessive exercise in heart attack survivors. Mayo Clin Proc. 2014 Sep;89(9):1187–1194. doi: 10.1016/j.mayocp.2014.05.006. [DOI] [PubMed] [Google Scholar]
- 15.Franklin BA, Thompson PD, Al-Zaiti SS, et al. Exercise-Related Acute Cardiovascular Events and Potential Deleterious Adaptations Following Long-Term Exercise Training: Placing the Risks Into Perspective-An Update: A Scientific Statement From the American Heart Association. Circulation. 2020 Feb 26; doi: 10.1161/CIR.0000000000000749. CIR0000000000000749. [DOI] [PubMed] [Google Scholar]
- 16.Paffenbarger RS, Jr, Hyde RT, Wing AL, Hsieh CC. Physical activity, all-cause mortality, and longevity of college alumni. The New England journal of medicine. 1986 Mar 6;314(10):605–613. doi: 10.1056/NEJM198603063141003. [DOI] [PubMed] [Google Scholar]
- 17.Hellsten Y, Nyberg M. Cardiovascular Adaptations to Exercise Training. Compr Physiol. 2015 Dec 15;6(1):1–32. doi: 10.1002/cphy.c140080. [DOI] [PubMed] [Google Scholar]
- 18.Sharma S, Drezner JA, Baggish A, et al. International recommendations for electrocardiographic interpretation in athletes. Eur Heart J. 2018 Apr 21;39(16):1466–1480. doi: 10.1093/eurheartj/ehw631. [DOI] [PubMed] [Google Scholar]
- 19.Karjalainen J, Kujala UM, Kaprio J, Sarna S, Viitasalo M. Lone atrial fibrillation in vigorously exercising middle aged men: case-control study. BMJ. 1998 Jun 13;316(7147):1784–1785. doi: 10.1136/bmj.316.7147.1784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Andersen K, Farahmand B, Ahlbom A, et al. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J. 2013 Dec;34(47):3624–3631. doi: 10.1093/eurheartj/eht188. [DOI] [PubMed] [Google Scholar]
- 21.Calvo N, Ramos P, Montserrat S, et al. Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control study. Europace. 2016 Jan;18(1):57–63. doi: 10.1093/europace/euv216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Myrstad M, Nystad W, Graff-Iversen S, et al. Effect of years of endurance exercise on risk of atrial fibrillation and atrial flutter. Am J Cardiol. 2014 Oct 15;114(8):1229–1233. doi: 10.1016/j.amjcard.2014.07.047. [DOI] [PubMed] [Google Scholar]
- 23.Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009 Sep;11(9):1156–1159. doi: 10.1093/europace/eup197. [DOI] [PubMed] [Google Scholar]
- 24.Qureshi WT, Alirhayim Z, Blaha MJ, et al. Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project. Circulation. 2015 May 26;131(21):1827–1834. doi: 10.1161/CIRCULATIONAHA.114.014833. [DOI] [PubMed] [Google Scholar]
- 25.Ricci C, Gervasi F, Gaeta M, Smuts CM, Schutte AE, Leitzmann MF. Physical activity volume in relation to risk of atrial fibrillation. A non-linear meta-regression analysis. Eur J Prev Cardiol. 2018 May;25(8):857–866. doi: 10.1177/2047487318768026. [DOI] [PubMed] [Google Scholar]
- 26.Baldesberger bS, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2008 Jan;29(1):71–78. doi: 10.1093/eurheartj/ehm555. [DOI] [PubMed] [Google Scholar]
- 27.Heidbuchel H, Anne W, Willems R, Adriaenssens B, Van de Werf F, Ector H. Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter. Int J Cardiol. 2006 Feb 8;107(1):67–72. doi: 10.1016/j.ijcard.2005.02.043. [DOI] [PubMed] [Google Scholar]
- 28.Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol. 2002 Aug 7;40(3):446–452. doi: 10.1016/s0735-1097(02)01977-0. [DOI] [PubMed] [Google Scholar]
- 29.La Gerche A, Claessen G, Dymarkowski S, et al. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes. Eur Heart J. 2015 Aug 7;36(30):1998–2010. doi: 10.1093/eurheartj/ehv202. [DOI] [PubMed] [Google Scholar]
- 30.Heidbuchel H, Prior DL, La Gerche A. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence? Br J Sports Med. 2012 Nov;46(Suppl 1):i44–50. doi: 10.1136/bjsports-2012-091162. [DOI] [PubMed] [Google Scholar]
- 31.van de Schoor FR, Aengevaeren VL, Hopman MT, et al. Myocardial Fibrosis in Athletes. Mayo Clin Proc. 2016 Nov;91(11):1617–1631. doi: 10.1016/j.mayocp.2016.07.012. [DOI] [PubMed] [Google Scholar]
- 32.Wilson M, O’Hanlon R, Prasad S, et al. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol. 1985 2011 Jun;110(6):1622–1626. doi: 10.1152/japplphysiol.01280.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Breuckmann F, Mohlenkamp S, Nassenstein K, et al. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology. 2009 Apr;251(1):50–57. doi: 10.1148/radiol.2511081118. [DOI] [PubMed] [Google Scholar]
- 34.Mohlenkamp S, Lehmann N, Breuckmann F, et al. Running: the risk of coronary events : Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J. 2008 Aug;29(15):1903–1910. doi: 10.1093/eurheartj/ehn163. [DOI] [PubMed] [Google Scholar]
- 35.La Gerche A, Heidbuchel H, Burns AT, et al. Disproportionate exercise load and remodeling of the athlete’s right ventricle. Med Sci Sports Exerc. 2011 Jun;43(6):974–981. doi: 10.1249/MSS.0b013e31820607a3. [DOI] [PubMed] [Google Scholar]
- 36.Eijsvogels TMH, Oxborough DL, O’Hanlon R, et al. Global and regional cardiac function in lifelong endurance athletes with and without myocardial fibrosis. Eur J Sport Sci. 2017 Nov;17(10):1297–1303. doi: 10.1080/17461391.2017.1373864. [DOI] [PubMed] [Google Scholar]
- 37.Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008 Mar 27;358(13):1336–1345. doi: 10.1056/NEJMoa072100. [DOI] [PubMed] [Google Scholar]
- 38.Kermott CA, Schroeder DR, Kopecky SL, Behrenbeck TR. Cardiorespiratory Fitness and Coronary Artery Calcification in a Primary Prevention Population. Mayo Clin Proc Innov Qual Outcomes. 2019 Jun;3(2):122–130. doi: 10.1016/j.mayocpiqo.2019.04.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Merghani A, Maestrini V, Rosmini S, et al. Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile. Circulation. 2017 Jul 11;136(2):126–137. doi: 10.1161/CIRCULATIONAHA.116.026964. [DOI] [PubMed] [Google Scholar]
- 40.DeFina LF, Radford NB, Barlow CE, et al. Association of All-Cause and Cardiovascular Mortality With High Levels of Physical Activity and Concurrent Coronary Artery Calcification. JAMA Cardiol. 2019 Feb 1;4(2):174–181. doi: 10.1001/jamacardio.2018.4628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bruning RS, Sturek M. Benefits of exercise training on coronary blood flow in coronary artery disease patients. Prog Cardiovasc Dis. 2015 Mar-Apr;57(5):443–453. doi: 10.1016/j.pcad.2014.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Schwartz RS, Merkel Kraus S, Schwartz JG, et al. Inceased coronary artery plaque volume among male marathon runners. Mo Med. 2014;111(2):85–90. [PMC free article] [PubMed] [Google Scholar]
- 43.Sharma S, Merghani A, Mont L. Exercise and the heart: the good, the bad, and the ugly. Eur Heart J. 2015 Jun 14;36(23):1445–1453. doi: 10.1093/eurheartj/ehv090. [DOI] [PubMed] [Google Scholar]
- 44.Harmon KG, Drezner JA, Wilson MG, Sharma S. Incidence of sudden cardiac death in athletes: a state-of-the-art review. Br J Sports Med. 2014 Aug;48(15):1185–1192. doi: 10.1136/bjsports-2014-093872. [DOI] [PubMed] [Google Scholar]
- 45.D’Silva A, Sharma S. Exercise, the athlete’s heart, and sudden cardiac death. Phys Sportsmed. 2014 May;42(2):100–113. doi: 10.3810/psm.2014.05.2062. [DOI] [PubMed] [Google Scholar]
- 46.Hart L. Marathon-related cardiac arrest. Clin J Sport Med. 2013 Sep;23(5):409–410. doi: 10.1097/01.jsm.0000433155.97054.c8. [DOI] [PubMed] [Google Scholar]
- 47.Mathews SC, Narotsky DL, Bernholt DL, et al. Mortality among marathon runners in the United States, 2000–2009. Am J Sports Med. 2012 Jul;40(7):1495–1500. doi: 10.1177/0363546512444555. [DOI] [PubMed] [Google Scholar]
- 48.Harris KM, Creswell LL, Haas TS, et al. Death and Cardiac Arrest in U.S. Triathlon Participants, 1985 to 2016: A Case Series. Ann Intern Med. 2017 Oct 17;167(8):529–535. doi: 10.7326/M17-0847. [DOI] [PubMed] [Google Scholar]
- 49.Legaz-Arrese A, George K, Carranza-Garcia LE, Munguia-Izquierdo D, Moros-Garcia T, Serrano-Ostariz E. The impact of exercise intensity on the release of cardiac biomarkers in marathon runners. Eur J Appl Physiol. 2011 Dec;111(12):2961–2967. doi: 10.1007/s00421-011-1922-3. [DOI] [PubMed] [Google Scholar]
- 50.La Gerche A, Burns AT, Mooney DJ, et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012 Apr;33(8):998–1006. doi: 10.1093/eurheartj/ehr397. [DOI] [PubMed] [Google Scholar]
- 51.Schnohr P, O’Keefe JH, Holtermann A, et al. Various Leisure-Time Physical Activities Associated With Widely Divergent Life Expectancies: The Copenhagen City Heart Study. Mayo Clin Proc. 2018 Dec;93(12):1775–1785. doi: 10.1016/j.mayocp.2018.06.025. [DOI] [PubMed] [Google Scholar]